Ładuje się......
Risk of Postoperative Surgical Site Infections after Vedolizumab versus Anti-Tumor Necrosis Factor Therapy: A Propensity-Score Matching Analysis in Inflammatory Bowel Disease
BACKGROUND: Perioperative vedolizumab (VDZ) and anti-tumor necrosis factor (TNFi) therapies are implicated in causing postoperative complications in inflammatory bowel disease (IBD). AIM: To compare the risk of surgical site infections (SSIs) between VDZ- and TNFi-treated IBD patients in propensity-...
Zapisane w:
| Wydane w: | Aliment Pharmacol Ther |
|---|---|
| Główni autorzy: | , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6043399/ https://ncbi.nlm.nih.gov/pubmed/29876995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14842 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|